Market Overview

PositiveID Enters License, Teaming Agreement with Boeing

Related BA
Boeing, BOC Aviation Announce Order For 82 Airplanes; Largest In BOC Aviation's History
Can Boeing (BA) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Second Reading on 2Q GDP, Much More Data Due Next Week (Fox Business)

PositiveID Corporation an emerging growth company and developer of airborne bio-threat detection systems for America's homeland defense industry as well as advanced technologies for rapid medical testing and diabetes management, today announced it has entered into a license agreement and a teaming agreement with The Boeing Company (NYSE: BA), including a license fee to PositiveID of $2.5 million.

The license agreement provides Boeing the exclusive license to manufacture and sell PositiveID's M-BAND (Microfluidics-based Bioagent Networked Detector) airborne bio-threat detector for the U.S. Department of Homeland Security's ("DHS") BioWatch Generation 3 opportunity, as well as other opportunities (government or commercial) that may arise in the North American market. Under the teaming agreement, PositiveID will retain exclusive rights to serve as the reagent and assay supplier of the M-BAND systems to Boeing in the U.S. market. PositiveID will also retain the right to sell M-BAND units, reagents and assays in international markets.

PositiveID's M-BAND, developed under contract for DHS Science and Technology Division, is a bioaerosol monitor with fully integrated systems with sample collection, processing and detection modules that continuously analyze air samples for the detection of bacteria, viruses, and toxins. Results from individual M-BAND instruments are reported via a secure wireless network in real time to give an accurate and up to date status for fielded instruments in the aggregate.

Posted-In: News

 

Related Articles (BA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters